-+ 0.00%
-+ 0.00%
-+ 0.00%

ACUMEN PHARMACEUTICALS ANNOUNCES NOMINATION OF TWO ENHANCED BRAIN DELIVERY™ (EBD™) DEVELOPMENT CANDIDATES FOR THE TREATMENT OF ALZHEIMER’S DISEASE

Reuters·06/16/2026 11:30:00

Please log in to view news